038070 Stock Chart & Stats
₩4115.00
₩105.00(2.62%)
―
--
Day’s Range― - ―
52-Week Range₩3,600.00 - ₩7,779.64
Previous CloseN/A
VolumeN/A
Average Volume (3M)21.61K
Market Cap
₩36.32B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)71.2
Beta0.32
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding9,300,676
10 Day Avg. Volume11,629
30 Day Avg. Volume21,606
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
038070 FAQ
What was Seoulin Bioscience Co.,Ltd.’s price range in the past 12 months?
Seoulin Bioscience Co.,Ltd. lowest stock price was ₩3600.00 and its highest was ₩7779.64 in the past 12 months.
What is Seoulin Bioscience Co.,Ltd.’s market cap?
Seoulin Bioscience Co.,Ltd.’s market cap is ₩36.32B.
When is Seoulin Bioscience Co.,Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Seoulin Bioscience Co.,Ltd.’s earnings last quarter?
Seoulin Bioscience Co.,Ltd. released its earnings results on May 15, 2026. The company reported ₩18.484 earnings per share for the quarter, beating the consensus estimate of N/A by ₩18.484.
Is Seoulin Bioscience Co.,Ltd. overvalued?
According to Wall Street analysts Seoulin Bioscience Co.,Ltd.’s price is currently Undervalued.
Does Seoulin Bioscience Co.,Ltd. pay dividends?
Seoulin Bioscience Co.,Ltd. does not currently pay dividends.
What is Seoulin Bioscience Co.,Ltd.’s EPS estimate?
Seoulin Bioscience Co.,Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Seoulin Bioscience Co.,Ltd. have?
Seoulin Bioscience Co.,Ltd. has 9,300,676 shares outstanding.
What happened to Seoulin Bioscience Co.,Ltd.’s price movement after its last earnings report?
Seoulin Bioscience Co.,Ltd. reported an EPS of ₩18.484 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -2.467%.
Which hedge fund is a major shareholder of Seoulin Bioscience Co.,Ltd.?
Currently, no hedge funds are holding shares in KR:038070
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
MemRAY BT Co. LTD.
―
WOOJUNG BIO, Inc.
―
Gencurix, Inc.
―
Aligned Genetics, Inc.
―
Oncocross Co., Ltd.
―